News | February 18, 2014

Robotic-Assisted Coronary Angioplasty Highlighted During CRT 2014

Cordinus Vascular Robotics CorPath Cath Lab Robotics Systems Angioplasty

February 18, 2014 — Corindus Vascular Robotics is a developer of precision vascular robotics that present on robotics in the future of cath lab at the Cardiovascular Research Technologies (CRT) conference, Feb. 22–25, 2014 in Washington, D.C. Additionally, cases submitted by users of its CorPath Vascular Robotics System have been accepted for presentation at the conference.

The CorPath System is an U.S. Food and Drug Administration (FDA)-cleared technology that enables precise, robotic-assisted angioplasties to treat coronary artery disease. Dr. Giora Weisz, chairman of cardiology at Shaare Zedek Medical Center in Israel, will discuss this technology in the “Cath Lab of the Future” and cases accepted to CRT will discuss current clinical use of CorPath.

Puneet Sharma, M.D., interventional cardiologist at Sanford Clinic in Aberdeen, S.D., had a case selected as an Interesting Case for the conference. Sharma’s case submission details the first robotic-assisted stent placement in acute heart-attack within the 90 minute door to balloon guideline. Sharma used CorPath to complete a procedure in 68 minutes of the patient’s arrival. 

The CorPath System enables precisely controlled, robotic-assisted angioplasties while the physician is seated in a lead-lined interventional cockpit protected from radiation exposure. CorPath enables the cardiologist to advance stents and guidewires millimeter-by-millimeter via a joystick.

The Corpath system can be seen throughout the CRT conference in the following settings:

  • Weisz's presentation, Feb. 25 at 2:10 p.m. in Palladian Room during the Cardiovascular Innovations session.
  • Sharma’s submission will be presented online at
  • Corindus Vascular Robotics will be at booth #102 with a demo of the CorPath.

For more information:

Related Content

Bivalirudin exhibited an improvement in 30-day all-cause mortality when injected post PCI.
News | Antiplatelet and Anticoagulation Therapies| August 16, 2017
August 16, 2017 — A study has examined the efficacies of various post-percutaneous coronary intervention (PCI) bivali
CMS considers eliminating cardiac bundled payments.
Feature | Business| August 16, 2017 | Dave Fornell
August 16, 2017 — The Centers for Medicare and Medicaid Services (CMS) announced a proposed rule to reduce the number
News | Drug-Eluting Balloons| August 15, 2017
Surmodics Inc. announced receipt of an investigational device exemption (IDE) from the U.S. Food and Drug...
The Vascular Dynamics MobiusHD device enhances the carotid baroreceptors to reduce resistant hypertension.
News | Hypertension| August 15, 2017
Aug. 15, 2017 — The U.S. Food and Drug Administration (FDA) has approved the Vascular Dynamics Inc.
Four Blue Cross Blue Shield Companies Issue Positive Medical Policies on HeartFlow FFRct Analysis
News | FFR Catheters| August 09, 2017
HeartFlow Inc. announced that four Blue Cross Blue Shield companies have each issued a positive medical policy for the...
Ra Medical Systems Granted Broad Patent for DABRA Catheter
News | Peripheral Artery Disease (PAD)| August 09, 2017
August 9, 2017 — Ra Medical Systems announced that the United States Patent and Trademark Office (USPTO) has granted
Roxwood Medical Announces Agreement With Abbott for U.S. Product Distribution
News | Catheters| August 09, 2017
Roxwood Medical Inc. recently announced it has entered into an exclusive agreement with Abbott for distribution of...
New Jersey Researcher Exploring New Stem Cell Therapies for Heart Attacks
News | Stem Cell Therapies| August 04, 2017
In petri dishes in her campus laboratory at New Jersey Institute of Technology, Alice Lee is developing colonies of...
Abbott Initiates XIENCE Short DAPT Clinical Trial
News | Antiplatelet and Anticoagulation Therapies| August 03, 2017
Abbott recently announced the first patient has been enrolled in a clinical study evaluating the short-term use of...
Overlay Init